Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM).
Graber J, Young R, Gupta A, Shah A, Chan T, Zhang Z, Shi W, Beal K, Omuro A. Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM). Journal Of Clinical Oncology 2011, 29: 2009-2009. DOI: 10.1200/jco.2011.29.15_suppl.2009.Peer-Reviewed Original ResearchMagnetic resonance perfusionEarly progression